Cargando…

Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies

Background: One of the most frequently used medications for treating gastrointestinal disorders is proton pump inhibitor (PPI), which reportedly has potential adverse effects. Although the relationship between the use of PPIs and the risk of pancreatic cancer has been extensively investigated, the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Hee-Eun, Kim, A-Sol, Kim, Mi-Rae, Ko, Hae-Jin, Jung, Min Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463819/ https://www.ncbi.nlm.nih.gov/pubmed/32784492 http://dx.doi.org/10.3390/cancers12082220

Ejemplares similares

Effectiveness of proton pump inhibitor in unexplained chronic cough
por: Park, Hye Jung, et al.
Publicado: (2017)

Association between Proton Pump Inhibitor Use and Parkinson’s Disease in a Korean Population
por: Kim, Ji-Hee, et al.
Publicado: (2022)

Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis
por: Liao, Shengtao, et al.
Publicado: (2019)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Predictive Factors of Response to Proton Pump Inhibitors in Korean Patients With Gastroesophageal Reflux Disease
por: Kim, Sung Eun, et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea
por: Jo, Hyun Jin, et al.
Publicado: (2013)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Epidemiological Study Assessing the Overuse of Proton Pump Inhibitors in Lebanese Population
por: Hoteit, Mayssaa, et al.
Publicado: (2020)

Effects of Proton Pump Inhibitors on Patient Survival in Patients Undergoing Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis
por: Zhou, Wence, et al.
Publicado: (2022)

Proton Pump Inhibitors Exert Anti-Allergic Effects by Reducing TCTP Secretion
por: Choi, Sunghee, et al.
Publicado: (2009)

Clinical Predictors for Response to Proton Pump Inhibitor Treatment in Patients With Globus
por: Jeon, Hye Kyung, et al.
Publicado: (2013)

Use of proton pump inhibitor may be associated with progression of cerebral small vessel disease
por: Kang, Min Kyoung, et al.
Publicado: (2022)

Associations between proton pump inhibitors and Alzheimer’s disease: a nested case–control study using a Korean nationwide health screening cohort
por: Choi, Hyo Geun, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Does Proton Pump Inhibitor Increase the Clostridium difficile Infection Risk in the Treatment and Prophylaxis of Stress Ulcers than Histanime-2 Receptor Antagonist?
por: Eun, Chang Soo
Publicado: (2017)

Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions
por: Yang, Hee Gyu, et al.
Publicado: (2023)

Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
por: Lee, Yoo-Young, et al.
Publicado: (2015)

Proton Pump Inhibitor-Related Gastric Mucosal Changes
por: Kim, Gwang Ha
Publicado: (2021)

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Proton-pump inhibitor use does not affect semen quality in subfertile men
por: Keihani, Sorena, et al.
Publicado: (2018)

Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2019)

Proton Pump Inhibitor Use before Percutaneous Endoscopic Gastrostomy Is Associated with Adverse Outcomes
por: Im, Jong Pil, et al.
Publicado: (2014)

Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021)

Proton pump inhibitor-induced fundic gland polyposis
por: Park, Young Joo, et al.
Publicado: (2017)

Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer
por: Wang, Xiaoyu, et al.
Publicado: (2017)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019)

Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?
por: Kim, Ka Rham, et al.
Publicado: (2015)

Does proton pump inhibitors use increase risk of digestive tumors?: A 2-sample Mendelian randomization study
por: Zhao, Ruiqi, et al.
Publicado: (2023)

The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia: A Systematic Review and Meta-Analysis
por: Park, Chan Hyuk, et al.
Publicado: (2014)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
por: Lee, Yong Kang, et al.
Publicado: (2023)

Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals
por: Poly, Tahmina Nasrin, et al.
Publicado: (2022)

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ald76n4kq76q5lpk4lbtpej1bp